Citadel Advisors’s Novavax NVAX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.39M | Sell |
293,900
-182,700
| -38% | -$1.66M | ﹤0.01% | 5714 |
|
|
2025
Q4 | $3.2M | Sell |
476,600
-14,300
| -3% | -$108K | ﹤0.01% | 5051 |
|
|
2025
Q3 | $4.26M | Sell |
490,900
-25,400
| -5% | -$198K | ﹤0.01% | 4655 |
|
|
2025
Q2 | $3.25M | Buy |
516,300
+4,700
| +0.9% | +$31.1K | ﹤0.01% | 4839 |
|
|
2025
Q1 | $3.28M | Sell |
511,600
-203,100
| -28% | -$1.68M | ﹤0.01% | 4603 |
|
|
2024
Q4 | $5.75M | Sell |
714,700
-358,300
| -33% | -$3.45M | ﹤0.01% | 3740 |
|
|
2024
Q3 | $13.6M | Buy |
1,073,000
+78,700
| +8% | +$1.02M | ﹤0.01% | 2500 |
|
|
2024
Q2 | $12.6M | Buy |
994,300
+464,900
| +88% | +$4.68M | ﹤0.01% | 2499 |
|
|
2024
Q1 | $2.53M | Sell |
529,400
-493,800
| -48% | -$2.29M | ﹤0.01% | 5069 |
|
|
2023
Q4 | $4.91M | Sell |
1,023,200
-245,500
| -19% | -$1.5M | ﹤0.01% | 3821 |
|
|
2023
Q3 | $9.19M | Buy |
1,268,700
+187,800
| +17% | +$1.5M | ﹤0.01% | 2793 |
|
|
2023
Q2 | $8.03M | Sell |
1,080,900
-934,300
| -46% | -$7.35M | ﹤0.01% | 2969 |
|
|
2023
Q1 | $14M | Buy |
2,015,200
+76,400
| +4% | +$703K | ﹤0.01% | 2369 |
|
|
2022
Q4 | $19.9M | Buy |
1,938,800
+689,700
| +55% | +$12.2M | ﹤0.01% | 1971 |
|
|
2022
Q3 | $22.7M | Sell |
1,249,100
-284,200
| -19% | -$12.3M | 0.01% | 1754 |
|
|
2022
Q2 | $78.9M | Buy |
1,533,300
+68,100
| +5% | +$3.53M | 0.02% | 717 |
|
|
2022
Q1 | $108M | Buy |
1,465,200
+97,600
| +7% | +$8.7M | 0.02% | 618 |
|
|
2021
Q4 | $196M | Buy |
1,367,600
+416,700
| +44% | +$71.6M | 0.04% | 357 |
|
|
2021
Q3 | $197M | Buy |
950,900
+28,400
| +3% | +$6.26M | 0.04% | 343 |
|
|
2021
Q2 | $196M | Buy |
922,500
+186,600
| +25% | +$34.2M | 0.04% | 325 |
|
|
2021
Q1 | $133M | Buy |
735,900
+71,700
| +11% | +$14.3M | 0.03% | 451 |
|
|
2020
Q4 | $74.1M | Sell |
664,200
-216,200
| -25% | -$23M | 0.02% | 711 |
|
|
2020
Q3 | $95.4M | Buy |
880,400
+599,400
| +213% | +$73M | 0.03% | 485 |
|
|
2020
Q2 | $23.4M | Buy |
281,000
+91,700
| +48% | +$3.51M | 0.01% | 1380 |
|
|
2020
Q1 | $2.57M | Buy |
189,300
+128,500
| +211% | +$1.09M | ﹤0.01% | 3731 |
|
|
2019
Q4 | $242K | Sell |
60,800
-109,500
| -64% | -$475K | ﹤0.01% | 7907 |
|
|
2019
Q3 | $855K | Buy |
170,300
+149,700
| +727% | +$819K | ﹤0.01% | 5855 |
|
|
2019
Q2 | $121K | Sell |
20,600
-570
| -3% | -$4.49K | ﹤0.01% | 8462 |
|
|
2019
Q1 | $233K | Buy |
21,170
+7,575
| +56% | +$239K | ﹤0.01% | 7987 |
|
|
2018
Q4 | $500K | Buy |
13,595
+8,330
| +158% | +$323K | ﹤0.01% | 6391 |
|
|
2018
Q3 | $198K | Buy |
5,265
+3,915
| +290% | +$110K | ﹤0.01% | 8223 |
|
|
2018
Q2 | $36K | Sell |
1,350
-3,330
| -71% | -$113K | ﹤0.01% | 8509 |
|
|
2018
Q1 | $197K | Buy |
4,680
+720
| +18% | +$28.9K | ﹤0.01% | 7366 |
|
|
2017
Q4 | $98K | Sell |
3,960
-1,150
| -23% | -$28.1K | ﹤0.01% | 7443 |
|
|
2017
Q3 | $117K | Buy |
5,110
+255
| +5% | +$5.71K | ﹤0.01% | 6979 |
|
|
2017
Q2 | $112K | Sell |
4,855
-925
| -16% | -$18.1K | ﹤0.01% | 6866 |
|
|
2017
Q1 | $148K | Sell |
5,780
-8,915
| -61% | -$245K | ﹤0.01% | 6693 |
|
|
2016
Q4 | $370K | Sell |
14,695
-11,350
| -44% | -$331K | ﹤0.01% | 5366 |
|
|
2016
Q3 | $1.08M | Buy |
26,045
+13,770
| +112% | +$1.78M | ﹤0.01% | 3738 |
|
|
2016
Q2 | $1.78M | Buy |
12,275
+5,065
| +70% | +$580K | ﹤0.01% | 2871 |
|
|
2016
Q1 | $744K | Buy |
7,210
+555
| +8% | +$59.5K | ﹤0.01% | 3844 |
|
|
2015
Q4 | $1.12M | Buy |
6,655
+1,080
| +19% | +$166K | ﹤0.01% | 3431 |
|
|
2015
Q3 | $788K | Sell |
5,575
-320
| -5% | -$71.8K | ﹤0.01% | 4146 |
|
|
2015
Q2 | $1.31M | Sell |
5,895
-210
| -3% | -$36.9K | ﹤0.01% | 3608 |
|
|
2015
Q1 | $1.01M | Buy |
6,105
+3,655
| +149% | +$593K | ﹤0.01% | 3908 |
|
|
2014
Q4 | $291K | Sell |
2,450
-1,180
| -33% | -$123K | ﹤0.01% | 5486 |
|
|
2014
Q3 | $303K | Sell |
3,630
-400
| -10% | -$36.2K | ﹤0.01% | 5250 |
|
|
2014
Q2 | $372K | Buy |
4,030
+2,505
| +164% | +$220K | ﹤0.01% | 4766 |
|
|
2014
Q1 | $138K | Buy |
1,525
+185
| +14% | +$20.7K | ﹤0.01% | 5878 |
|
|
2013
Q4 | $137K | Buy |
1,340
+55
| +4% | +$3.89K | ﹤0.01% | 5354 |
|
|
2013
Q3 | $81K | Buy |
1,285
+995
| +343% | +$56K | ﹤0.01% | 5485 |
|
|
2013
Q2 | $12K | Buy |
+290
| New | +$12.6K | ﹤0.01% | 6195 |
|
Other funds holding NVAX
SCM
VPM
VCM
S
Citadel Advisors's NVAX Position: Q1 2026 in Review
Citadel Advisors increased its Novavax (NVAX) stake by 4.7% in Q1 2026, buying an estimated $453K and bringing the position to 1,123,746 shares worth $9.15M. The position accounts for ﹤0.01% of the portfolio, ranked #3379.
Citadel Advisors first reported a position in NVAX in Q2 2013 and has held it in 49 quarters since. The position peaked at $145M in Q2 2021. 257 funds tracked by Wall St. Rank hold NVAX as of Q1 2026.
- Citadel Advisors held 1,123,746 shares of Novavax worth $9.15M as of Q1 2026.
- Citadel Advisors bought 50,019 Novavax shares in Q1 2026, an estimated $453K.
- Novavax made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #3379 holding.
- Citadel Advisors first reported a position in Novavax in Q2 2013 and has held it in 49 quarters since.
- Citadel Advisors's Novavax position peaked at $145M in Q2 2021.
- 257 funds tracked by Wall St. Rank held Novavax as of Q1 2026.
Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.